ArticleMolecular and clinical oncology2017

Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer.

Hidehiro Tajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.